Zusammenfassung
Die Leberchirurgie hat in den letzten beiden Jahrzehnten durch operationstechnische Weiterentwicklungen und Verbesserungen im perioperativen Management wesentliche Fortschritte erzielen können. Dadurch konnte die operationsbedingte Letalität insgesamt deutlich unter 5% gesenkt werden. Dies erlaubt es, immer ausgedehntere Leberresektionen vorzunehmen und die Indikationsstellung auch bei ungünstig lokalisierten Tumoren großzügig zu stellen. Eine weitgehend standardisierte Operationstechnik sowie neue Möglichkeiten der Organkonservierung und insbesondere der Immunsuppression haben dazu geführt, dass bei geeigneter Indikation auch die Lebertransplantation heutzutage als ein Routineverfahren bei der Behandlung von Leberzellkarzinomen angesehen wird. Die vorliegende Arbeit gibt einen Überblick über den gegenwärtigen Stand der chirurgischen Therapie für die häufigsten benignen Leberveränderungen sowie für das hepatozelluläre und cholangiozelluläre Karzinom.
Abstract
Hepatic surgery has made substantial advances in the last two decades due to technical developments and improvements in perioperative management. This has reduced surgery dependent mortality to less than 5%, and provides the possibility of carrying out more substantial hepatic resections and to interpret the indications more liberally, also for tumours localized unfavorably. A widely standardized surgical technique as well as new possibilities for organ conservation and, in particular, immunosuppression mean that given suitable indications, liver transplantation is today regarded as a routine procedure for the treatment of hepatocellular carcinoma. This work provides an overview of the current status of surgical therapy for the most frequent, benign liver tumours, as well as for hepatocellular and cholangiocellular carcinoma.
Literatur
D’Angelica M, Fong Y, Weber S et al. (2003) The role of staging laparoscopy in hepatobiliary malignancy:prospective analysis of 40 cases. Ann Surg Oncol 10: 183
Belghiti J, Cortes A, Abdalla EK et al. (2003) Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg 238: 885–893
Bilimoria MM, Lauwers GY, Doherty DA et al. (2001) Underlying liver disease, not tumor factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg 136: 528–535
Bismuth H, Chiche L, Castaing D (1995) Surgical treatment of hepatocellular carcinomas in noncirrhotic liver:experience with 68 liver resections. World J Surg 19: 35–41
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208–1236
Casavilla FA, Wallis Marsh JW, Iwatsuki S et al. (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185: 429–436
Cha CH, Ruo L, Fong Y et al. (2003) Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg 238: 315–323
Chang CH, Chau GY, Lui WY et al. (2004) Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver. Arch Surg 139: 320–325
Chen MF, Tsai HP, Jeng LB et al. (2003) Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers:univariate and multivariate analysis. World J Surg 27: 443–447
Decaens T, Roudot-Thoraval F, Bresson-Hadni S et al. (2005) Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma. Liver Transplant 11: 767–775
Dupont-Bierre E, Compagnon P, Raoul JLFayet et al. (2005) Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg 201: 663–670
Erdogan D, Busch OR, van Delden OM et al. (2006) Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 26: 433–438
Flemming P, Lehmann U, Steinemann D et al. (2006) Leberzelladenom – Entartungspotenzial und Abgrenzung vom hepatozellulären Karzinom. Pathologe 27: 238–243
Figueras J, Ibanez L, Ramos E et al. (2001) Selection criteria for liver transplantation in early-stage hepatocellular carcinoma with cirrhosis:results of a multicenter study. Liver Transplant 7: 877–883
Fong Y, Sun RL, Jarnagin W, Blumgart LH (1999) An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg 229: 790–800
Gouillat C, Manganas D, Saguier G et al. (1999) Resection of hepatocellular carcinoma in cirrhotic patients; long-term results in a prospective study. J Am Coll Surg 189: 282–290
Hanazaki K, Kajikawa S, Shimozawa N et al. (2002) Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis. Hepatogastroenterology 49: 311
Harrison LE, Fong Y, Klimstra DS et al. (1998) Surgical treatment of 32 patients with peripheral intrahepatic cholangiocarcinoma. Br J Surg 85: 1068
Hemming AW, Cattral MS, Reed AI et al. (2001) Liver transplantation for hepatocellular carcinoma. Ann Surg 233: 652–659
Houben W, McCall JL (1999) Liver transplantation for hepatocellular carcinoma in patients without underlying liver disease: a systematic review. Liver Transpl Surg 5: 91–95
Hwang S, Lee SG, Joh JW et al. (2005) Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transplant 11: 1265–1272
Inoue K, Makuuchi M, Takayama T et al. (2000) The separate-lesion type cholangiocarcinoma. Surgery 127: 498
Jonas S, Bechstein WO, Steinmüller T et al. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080–1086
Klintmalm GB (1998) Liver transplantation for hepatocellular carcinoma – a registry report of the impact of tumor characteristics on outcome. Ann Surg 228: 479–490
Lang H, Radtke A, Hindennach M et al. (2005) Impact of virtual tumor resection and computer-assisted risk analysis on operation planning and intraoperative strategy in major hepatic resection. Arch Surg 140: 629–638
Lang H, Sotiropoulos GC, Dömland M et al. (2005) Liver resection for hepatocellular carcinoma in the non-cirrhotic, non-fibrotic liver without underlying viral hepatitis. Br J Surg 92: 198–202
Lang H, Sotiropoulos GC, Dömland M et al. (2005) Extended hepatectomy for intrahepatic Cholangiocellular carcinoma (ICC) – when is it worthwhile? Single center experience with 27 resections in 50 patients over a 5-years-period. Ann Surg 241: 134
Lang H, Sotiropoulos GC, Brokalaki E et al. (2006) Chirurgische Therapie des intrahepatischen cholangiozellulären Karzinoms. Chirurg 77: 53–60
Laurent C, Blanc JF, Nobili S et al. (2005) Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg 201: 656–662
Lehmann U, Berg-Ribbe I, Wingen LU et al. (2005) Distinct methylation patterns of benign and malignant liver tumors revealed by quantitative methylation profiling. Clin Cancer Res 11: 3654–3660
Limmer J, Fleig WE, Leupold D et al. (1988) Hepatocellular carcinoma in type I glycogen storage disease. Hepatology 8: 531–537
Llovet JM, Bustamante J, Castells A et al. (1999). Natural history of untreated nonsurgical hepatocellular carcinoma: rational for the design and evaluation of therapeutic trials. Hepatology 29: 62–67
Lo CM, Fan ST, Liu CL et al. (2004) The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transplant 10: 440–447
Longeville JH, de la Hall P, Dolan P et al. (1997) Treatment of giant haemangioma of the liver with Kasabach-Merritt syndrome by orthotopic liver transplant – a case report. HPB Surgery 10: 159–162
Lu DS, Yu NC, Raman SS, Lassmann C et al. (2005) Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 41: 1130–1137
Malagó M, Sotiropoulos GC, Nadalin S et al. (2006) Living donor liver transplantation for hepatocellular carcinoma: a single.center preliminary report. Liver Transplant 12: 934–940
Mazzaferro V, Regalia E, Doci R et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Eng J Med 334: 693–699
Nagasue N, Ono T, Yamanoi A et al. (2001) Prognostic factors and survival after hepatic resection for hepatocellular carcinoma without cirrhosis. Br J Surg 88: 515–522
Ogata S, Belghiti J, Farges O et al. (2006) Sequential arterial and portal vein embolizations bifore right hepatectomy in patients with cirrhosis and hepatocellular carcinoma. Br J Surg 93: 1091–1098
Ohtsuka M, Ito H, Kimura F et al. (2002) Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing the survival. Br J Surg 89: 1525
Otto G, Herber S, Heise M et al. (2006) Response to transarterial chemoembolization as a biological selection criteria for liver transplantation in hepatocellular carcinoma. Liver Transplant 12: 1260–1267
Pichlmayr R, Weimann A, Oldhafer KJ et al. (1995) Role of liver transplantation in the treatment of unresectable liver cancer. World J Surg 19: 807–813
Portolani N, Coniglio A, Ghidoni S et al. (2006) Early and late recurrence after liver resection for hepatocellular carcinoma – prognostic and therapeutic implications. Ann Surg 243: 229–235
Regimbeau JM, Kianmanesh R, Farges O et al. (2002) Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery 131: 311–317
Schlitt HJ, Neipp M, Weimann A et al. (1999) Recurrence patterns of hepatocellular carcinoma and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17: 324–331
Sotiropoulos GC, Malagó M, Molmenti E et al. (2005) Liver transplantation for hepatocellular carcinoma in cirrhosis: Is clinical tumor classification prior to transplantation realistic? Transplantation 79: 483–487
Stipa F, Yoon SS, Liau KH et al. (2006) Outcome of patients with fibrolamellar hepatocellular carcinoma. Cancer 106: 1331–1338
Takayama T, Makuuchi M, Hirohashi S et al. (1990) Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma. Lancet 336: 1150–1153
Tepetes K, Selby R, Webb M et al. (1995) Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 130: 153–156
Terkivatan T, de Wilt JH, de Man RA et al. (2001) Treatment of ruptured hepatocellular adenoma. Br J Surg 88: 207–209
Todo S, Furukawa H (2004) Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg 240: 451–459
Weber SM, Jarnagin WR, Klimstra D et al. (2001) Intrahepatic cholangiocarcinoma: resectability, recurrence patterns, and outcomes. J Am Coll Surg 193: 384
Weimann A, Ringe B, Klempnauer J et al. (1997) Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 21: 983–991
Weimann A, Schlitt HJ, Oldhafer KJ et al. (1999) Is liver transplantation superior to resection in early stage hepatocellular carcinoma? Transplant Proc 31: 500–550
Weimann A, Varnholt H, Schlitt HJ et al. (2000) Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocarcinoma. Br J Surg 87: 182
Wilkens L, Bredt M, Flemming P et al. (2001) Differentiation of liver cell adenomas from well-differentiated hepatocellular carcinomas by comparative genomic hybridization J Pathol 193: 476–482
Wu CC, Ho YZ, Lin Ho W et al. (1995) Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg 82: 122–126
Yao FY, Ferrell L, Bass NM et al. (2001) Liver transplantation for hepatocellular carcinoma:expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394–1403
Interessenkonflikt
Es besteht kein Interessenkonflikt. Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen. Die Präsentation des Themas ist unabhängig und die Darstellung der Inhalte produktneutral.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lang, H., Broelsch, C. Resektion und Transplantation bei Lebertumoren. Internist 48, 30–39 (2007). https://doi.org/10.1007/s00108-006-1780-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-006-1780-y
Schlüsselwörter
- Benigne Lebertumore
- Hepatozelluläres Karzinom
- Cholangiozelluläres Karzinom
- Lebertransplantation
- Leberresektion